Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009
- PMID: 23637091
- PMCID: PMC3720770
- DOI: 10.1002/pds.3447
Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009
Abstract
Background: Few population-based studies have reported the prevalence of psoriatic disease.
Objective: We validated computerized diagnoses to estimate the prevalence of psoriasis and psoriatic arthritis.
Method: We identified adults with ≥1 ICD-9 diagnosis codes of 696.0 (psoriatic arthritis) or 696.1 (psoriasis) in clinical encounter data during 1996-2009 and used chart review to confirm the diagnoses in random samples of patients. We then used the best performing case-finding algorithms to estimate the point prevalence of psoriasis and psoriatic arthritis.
Results: The number of persons with a diagnosis for psoriasis (ICD-9 code 696.1) was 87 827. Chart review of a random sample of 101 cases with at least one dermatologist-rendered psoriasis code revealed a positive predictive value (PPV) of 90% (95% CI, 83-95) with sensitivity of 88% (95% CI, 80-93). Psoriatic arthritis (code 696.0) was recorded for 5187 patients, with the best performing algorithm requiring ≥2 diagnoses recorded by a rheumatologist or ≥1 diagnosis recorded by a rheumatologist together with ≥1 psoriasis diagnoses recorded by a dermatologist; the PPV was 80% (95% CI, 70-88) with sensitivity 73% (95% CI, 63-82). Among KPNC adults, the point prevalence of psoriasis, with or without psoriatic arthritis, was 939 (95% CI, 765-1142) per 100 000, and the overall prevalence of psoriatic arthritis, with or without psoriasis, was 68 (95% CI, 54-84) per 100 000.
Conclusion: Within an integrated health care delivery system, the use of computerized diagnoses rendered by relevant disease specialists is a valid method for identifying individuals with psoriatic disease.
Keywords: computerized medical information; epidemiology; incidence, prevalence, health maintenance organizations; pharmacoepidemiology; psoriasis; psoriatic arthritis.
Copyright © 2013 John Wiley & Sons, Ltd.
Conflict of interest statement
Figures
Similar articles
-
Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden--a population-based register study.PLoS One. 2014 May 29;9(5):e98024. doi: 10.1371/journal.pone.0098024. eCollection 2014. PLoS One. 2014. PMID: 24875275 Free PMC article.
-
Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics.J Am Acad Dermatol. 2014 Oct;71(4):649-55. doi: 10.1016/j.jaad.2014.05.010. Epub 2014 Jun 25. J Am Acad Dermatol. 2014. PMID: 24974240 Clinical Trial.
-
Identifying Psoriasis and Psoriatic Arthritis Patients in Retrospective Databases When Diagnosis Codes Are Not Available: A Validation Study Comparing Medication/Prescriber Visit-Based Algorithms with Diagnosis Codes.Value Health. 2018 Jan;21(1):110-116. doi: 10.1016/j.jval.2017.06.012. Epub 2017 Aug 1. Value Health. 2018. PMID: 29304935
-
A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data.Vaccine. 2013 Dec 30;31 Suppl 10:K41-61. doi: 10.1016/j.vaccine.2013.03.075. Vaccine. 2013. PMID: 24331074 Review.
-
Epidemiology of Psoriasis and Psoriatic Arthritis in Italy-a Systematic Review.Curr Rheumatol Rep. 2018 May 30;20(7):43. doi: 10.1007/s11926-018-0753-1. Curr Rheumatol Rep. 2018. PMID: 29846817 Review.
Cited by
-
Mortality and major adverse cardiovascular events after glucagon-like peptide-1 receptor agonist initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A population-based study.PLoS One. 2024 Aug 8;19(8):e0308533. doi: 10.1371/journal.pone.0308533. eCollection 2024. PLoS One. 2024. PMID: 39116084 Free PMC article.
-
Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project.Clin Epidemiol. 2024 Jun 4;16:395-407. doi: 10.2147/CLEP.S445120. eCollection 2024. Clin Epidemiol. 2024. PMID: 38854895 Free PMC article.
-
Evaluation of a machine learning tool for the early identification of patients with undiagnosed psoriatic arthritis - A retrospective population-based study.J Transl Autoimmun. 2023 Aug 2;7:100207. doi: 10.1016/j.jtauto.2023.100207. eCollection 2023 Dec. J Transl Autoimmun. 2023. PMID: 37577138 Free PMC article.
-
Treatment Patterns and Healthcare Resource Utilization Among Newly Diagnosed Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, and Hidradenitis Suppurativa Patients with Past Diagnosis of an Inflammatory Condition: A Retrospective Cohort Analysis of Claims Data in the United States.Adv Ther. 2023 Oct;40(10):4358-4376. doi: 10.1007/s12325-023-02558-2. Epub 2023 Jul 24. Adv Ther. 2023. PMID: 37486558 Free PMC article.
-
Shared Genetic Risk Factors for Multiple Sclerosis/Psoriasis Suggest Involvement of Interleukin-17 and Janus Kinase-Signal Transducers and Activators of Transcription Signaling.Ann Neurol. 2023 Aug;94(2):384-397. doi: 10.1002/ana.26672. Epub 2023 May 18. Ann Neurol. 2023. PMID: 37127916 Free PMC article.
References
-
- Schön MP, Boehncke WH. Psoriasis. N Engl J Med. 2005;352(18):1899–912. - PubMed
-
- Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin. 1996;14(3):485–96. - PubMed
-
- Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005;53(4):573. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
